The Protective Effects of Bushen Daozhuo Granule on Chronic Non-bacterial Prostatitis

The Protective Effects of Bushen Daozhuo Granule on Chronic Non-bacterial Prostatitis

Background: Chronic non-bacterial prostatitis (CNP), one of the most common chronic diseases in urology, leads to pain in the prostate and dysuria, critically affecting the physical or mental health of patients. However, there are no standard treatment approaches for the treatment of CNP in the clin...

Full description

Bibliographic Details
Main Authors:	Dalin Sun, Dong Xing, Dandan Wang, Yuanyuan Liu, Bin Cai, Weimin Deng, Qinglin Hu, Wenjun Ma, Baofang Jin
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2024-01-01
Series:	Frontiers in Pharmacology
Subjects:	Bushen Daozhuo granule (BSDZG) chronic non-bacterial prostatitis (CNP) anti-inflammation anti-apoptosis TNF-α
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1281002/full

Similar Items

Mechanisms of Bushen Tiaoxue Granules against controlled ovarian hyperstimulation-induced abnormal morphology of endometrium based on network pharmacology
by: Jia-Cheng Zhang, et al.
Published: (2024-01-01)

Molecular mechanism of Bushen Huatan Prescription in the treatment of Polycystic ovary syndrome based on network pharmacology and bioinformatics
by: Linhui Huang, et al.
Published: (2022-12-01)

Bushen Tongluowan promotes chondrocyte proliferation through multi-gene regulation
by: Lu Bocheng, et al.
Published: (2022-12-01)

Bushen Huoxue formula for the treatment of diminished ovarian reserve: A combined metabolomics and integrated network pharmacology analysis
by: Pengfei Zeng, et al.
Published: (2023-09-01)

Persistence on anti-TNF therapy - data from Serbian National Spondyloarthritis Registry
by: Cvetković Jovana, et al.
Published: (2023-01-01)

Network Pharmacology with Metabolomics Study to Reveal the Mechanisms of Bushen Huoxue Formula in Intervertebral Disc Degeneration Treatment
by: Guo J, et al.
Published: (2024-02-01)

Bazi Bushen ameliorates age-related energy metabolism dysregulation by targeting the IL-17/TNF inflammatory pathway associated with SASP
by: Xiaogang Shen, et al.
Published: (2024-04-01)

Untargeted metabolomics analysis of the hippocampus and cerebral cortex identified the neuroprotective mechanisms of Bushen Tiansui formula in an aβ25-35-induced rat model of Alzheimer’s disease
by: Hongli Li, et al.
Published: (2022-10-01)

Network pharmacology and experimental validation to elucidate the pharmacological mechanisms of Bushen Huashi decoction against kidney stones
by: Haizhao Liu, et al.
Published: (2023-02-01)

Role of Bushen Huoxue Formula and transplanted endothelial progenitor cells play in promoting endplate microcirculation and attenuating intervertebral disc degeneration
by: Yue Xie, et al.
Published: (2024-03-01)

Mechanism of Bazi Bushen capsule in delaying the senescence of mesenchymal stem cells based on network pharmacology and experimental validation
by: Yaping Zhang, et al.
Published: (2024-03-01)

BuShen HuoXue decoction improves fertility through intestinal hsp-16.2-mediated heat-shock signaling pathway in Caenorhabditis elegans
by: Kanglu Wu, et al.
Published: (2023-06-01)

BushenHuoxue decoction suppresses M1 macrophage polarization and prevents LPS induced inflammatory bone loss by activating AMPK pathway
by: Shuangshuang Chen, et al.
Published: (2023-05-01)

Bushen Huoxue Recipe Alleviates Implantation Loss in Mice by Enhancing Estrogen–Progesterone Signals and Promoting Decidual Angiogenesis Through FGF2 During Early Pregnancy
by: Jiahui Ding, et al.
Published: (2018-05-01)

Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2022-11-01)

The Role of TNF-α and Anti-TNF-α Agents during Preconception, Pregnancy, and Breastfeeding
by: Katarzyna Romanowska-Próchnicka, et al.
Published: (2021-03-01)

Repositioning of clinically approved drug Bazi Bushen capsule for treatment of Aizheimer's disease using network pharmacology approach and in vitro experimental validation
by: Tongxing Wang, et al.
Published: (2023-07-01)

Bio‐experienced psoriasis patients treated with anti‐interleukin monoclonal antibodies are less likely to achieve PASI 90, PASI 100, PASI ≤ 1 and ≤3: Results from a cohort of 305 patients
by: Flavia Manzo Margiotta, et al.
Published: (2024-03-01)

Corrigendum: Bushen huoxue decoction inhibits RANKL-stimulated osteoclastogenesis and glucocorticoid-induced bone loss by modulating the NF-κB, ERK, and JNK signaling pathways
by: Yamei Liu, et al.
Published: (2023-02-01)

α-granule biogenesis: from disease to discovery
by: Chang Hua Chen, et al.
Published: (2017-02-01)

Demyelinating Disease Following Anti-TNFa Treatment (Adalimumab) in Patients with psoriasis: A Case Report (PP-13)
by: Mohammadreza Malek Zadeh
Published: (2023-01-01)

Efficacy and safety of adalimumab after failure of other anti-TNFα agents for plaque-type psoriasis: clinician behavior in real life clinical practice
by: Maria Esposito, et al.
Published: (2019-07-01)

Anti-tumor necrosis factor-α is potentially better than tumor necrosis factor-α as the biomarker for sarcopenia: Results from the I-Lan longitudinal aging study
by: Wei-Ju Lin, et al.
Published: (2023-02-01)

Bushen Yijing Decoction (BSYJ) exerts an anti-systemic sclerosis effect via regulating MicroRNA-26a /FLI1 axis
by: Zixuan Cheng, et al.
Published: (2021-01-01)

Bushen-Yizhi formula ameliorates mitochondrial dysfunction and oxidative stress via AMPK/Sirt1 signaling pathway in D-gal-induced aging rats
by: Yanfang Liao, et al.
Published: (2023-05-01)

Merkel cell carcinoma in a young female on infliximab
by: Alex Harrison, DO, et al.
Published: (2022-09-01)

The current understanding of the treatment chronic non-bacterial prostatitis with inflammatory component
by: Yu. Yu. Vinnik
Published: (2016-03-01)

Adalimumab in Treating Refractory Livedoid Vasculopathy
by: Xiao-Wen Huang, et al.
Published: (2022-04-01)

Factors associated with bone mineral density loss in patients with spondyloarthropathies: A 4-year follow-up study
by: Lina Vencevičienė, et al.
Published: (2015-11-01)

Bioactivity‐guided isolation of anti‐inflammatory limonins from Chukrasia tabularis
by: Jin‐Huang Shen, et al.
Published: (2022-12-01)

In Vitro Evaluation of Antioxidant, Anticancer, and Anti-Inflammatory Activities of Ethanolic Leaf Extract of Adenium obesum
by: Ahmad Alshehri, et al.
Published: (2022-07-01)

Pesquisa de autoanticorpos em pacientes com artrite psoriásica sob terapia anti-TNFα
by: Vilma S Trindade Viana, et al.

Can anti-TNFα Antibodies Affect SARS-CoV-2 Disease Outcomes?
by: Mohammad Reza Khazdair
Published: (2022-05-01)

Early instauration granulomatous pneumonitis associated with use of etanercept in seronegative spondyloarthropathy: Case report
by: Liliana Fernández-Trujillo, et al.
Published: (2020-01-01)

Looking beyond the Skin: Pathophysiology of Cardiovascular Comorbidity in Psoriasis and the Protective Role of Biologics
by: Isabel Andújar, et al.
Published: (2022-09-01)

Menstrual blood derived mesenchymal stem cells combined with Bushen Tiaochong recipe improved chemotherapy-induced premature ovarian failure in mice by inhibiting GADD45b expression in the cell cycle pathway
by: Fengyi Guo, et al.
Published: (2019-07-01)

Granulation /
by: Seville, J. P. K. (Jonathan P. K.), et al.
Published: (2007)

Shaping the Future of Behçet’s Uveitis Management: A Comprehensive Review of Efficacy, Challenges, and Prospects of Biologic Therapies
by: Biao Li, et al.
Published: (2023-07-01)

The use of Mycobacterium tuberculosis HspX and GlcB proteins to identify latent tuberculosis in rheumatoid arthritis patients
by: Bruna Daniella Souza Silva, et al.
Published: (2014-02-01)

Anti-inflammatory activity of cinnamon water extract <it>in vivo</it> and <it>in vitro</it> LPS-induced models
by: Hong Joung-Woo, et al.
Published: (2012-11-01)